Patents

US 7981424 B2: RAGE fusion proteins, formulations, and methods of use thereof

Granted
2011-07-19
Filed
2007-04-25 application 11789637
Type
Utility · 52 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Disclosed are RAGE fusion proteins comprising RAGE polypeptide sequences linked to a second, non-RAGE polypeptide. The RAGE fusion protein may utilize a RAGE polypeptide domain comprising a RAGE ligand binding site and an interdomain linker directly linked to the N-terminus of an immunoglobulin CH2 domain. Also disclosed are RAGE fusion protein formulations and the use of the RAGE fusion proteins and RAGE fusion protein formulations as therapeutics for RAGE-mediated pathologies.

Source: PVGPATDIS, file of 2026-04-10 (ipg110719.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
TransTech Pharma, LLC 28 patentsUS company or organizationHigh Point, NCPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Adnan M. M. MjalliOak Ridge, NC53PVGPATDIS, file of 2026-04-10
Robert RothleinGreenville, NC3PVGPATDIS, file of 2026-04-10
Ye TianJamestown, NC108PVGPATDIS, file of 2026-04-10
Jeffrey C. WebsterJamestown, NC4PVGPATDIS, file of 2026-04-10
Eric BenjaminJamestown, NC11PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K14/70503PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P1/04PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/62PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K38/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2021-01-27Release of security interest
Release of security interest
HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT signed 2021-01-21VTV THERAPEUTICS LLC HIGH POINT, NC55133/214PASDL, file of 2026-10-15
2018-04-18Security interest Security interest
Security interest
VTV THERAPEUTICS LLC signed 2018-04-09HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT FARMINGTON, CT45969/774PASDL, file of 2026-10-15
2015-09-24Correction
Corrective assignment to correct the receiving party data previously recorded at reel: 036254 frame: 0780. assignor(s) hereby confirms the assignment.
M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT signed 2015-07-29VTVX HOLDINGS I LLC HIGH POINT, NC36675/407ECORSEXC, file of 2026-09-25
2015-08-03Release of security interest
Release of security interest
M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT signed 2015-07-29VTVX HOLDINGS II LLC HIGH POINT, NC36254/780ECORSEXC, file of 2026-09-25
2015-07-31Assignment
Assignment of assignor's interest
VTVX HOLDINGS I LLC signed 2015-07-29VTV THERAPEUTICS LLC HIGH POINT, NC36242/354ECORSEXC, file of 2026-09-25
2015-07-30Name change
Change of name
VTV THERAPEUTICS LLC signed 2015-07-29VTVX HOLDINGS I LLC HIGH POINT, NC36236/165ECORSEXC, file of 2026-09-25
2015-06-25Name change
Change of name
TRANSTECH PHARMA, LLC signed 2015-05-18VTV THERAPEUTICS LLC HIGH POINT, NC36026/219ECORSEXC, file of 2026-09-25
2015-02-26Security interest Security interest
Security interest
TRANSTECH PHARMA, LLC signed 2015-02-25M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT NEW YORK, NY35103/356ECORSEXC, file of 2026-09-25
2014-04-07Release of security interest
Notice of release of security interest in patents for reel/frame 030982/0803
M&F TTP HOLDINGS LLC signed 2014-03-28TRANSTECH PHARMA, LLC HIGH POINT, NC32621/860ECORSEXC, file of 2026-09-25
2013-11-22Assignment
Assignment of assignor's interest
TRANSTECH PHARMA, INC. signed 2013-11-14TRANSTECH PHARMA, LLC HIGH POINT, NC31654/878ECORSEXC, file of 2026-09-25
2013-08-09Security interest Security interest
Security agreement
TRANSTECH PHARMA, INC. signed 2013-08-09M&F TTP HOLDINGS LLC C/O MACANDREWS & FORBES HOLDINGS INC. NEW YORK, NY30982/803ECORSEXC, file of 2026-09-25
2007-08-08Assignment
Assignment of assignor's interest
TIAN, YE EDWARD signed 2007-08-03
WEBSTER, JEFFREY C. signed 2007-08-03
BENJAMIN, ERIC J. signed 2007-08-06
ANDREWS, ROBERT C. signed 2007-08-07
MJALLI, ADNAN M.M. signed 2007-08-07
TRANSTECH PHARMA, INC. HIGH POINT, NC19665/71ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.